Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,519 | $1,568 | $1,023 | $958 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Cost of Goods Sold | $1,035 | $548 | $264 | $239 |
| Gross Profit | $1,484 | $1,020 | $759 | $719 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| R&D Expenses | $164 | $124 | $73 | $97 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $981 | $643 | $432 | $408 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $173 | $120 | $26 | $41 |
| Operating Expenses | $1,318 | $887 | $531 | $547 |
| Operating Income | $166 | $133 | $228 | $172 |
| % Margin | 6.6% | 8.5% | 22.3% | 17.9% |
| Other Income/Exp. Net | -$45 | $32 | $15 | $8 |
| Pre-Tax Income | $121 | $165 | $243 | $180 |
| Tax Expense | $18 | $43 | $53 | $31 |
| Net Income | $103 | $123 | $190 | $149 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS | 0.76 | 1.09 | 1.89 | 1.48 |
| % Growth | -30.3% | -42.3% | 27.7% | – |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| Weighted Avg Shares Out | 136 | 113 | 100 | 101 |
| Weighted Avg Shares Out Dil | 138 | 115 | 103 | 104 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $20 | $14 | $9 |
| Interest Expense | $4 | $0 | $0 | $0 |
| Depreciation & Amortization | $254 | $145 | $68 | $70 |
| EBITDA | $474 | $347 | $305 | $265 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |